Professor of Cardiology and Head of Research. Oslo University Hospital
Oslo, Norway
Joined April 2013
- Tweets364
- Following1.3K
- Followers1K
- Likes640
Dan Atar retweeted
Enormously honored and proud to present at the famous “Oxford Master Course in Clinical Trials” alongside some of the World’s most famous trialists: Sir Richard Peto, Sir Rory Collins, Professors Colin Baigent, Jane Armitage, Louise Bowman, Amanda Adler, Peter Jüni.
Dan Atar retweeted
Our new study from #JupiterGroup with @SABOURETCardio @dan_atar @mmamas1973
☀️#IPF and long term prognosis after #PPCI in #STEMI pts.
The association held across both sensitivity analyses: 3-year truncated HR 1.78 (1.23-2.58) and post-discharge landmark HR 1.52 (1.04-2.21). Single centre and observational, so external validation is the next step.
doi.org/10.1055/a-2945-5355
Dan Atar retweeted
What are the latest developments in atrial fibrillation, blood pressure management and cardiovascular prevention?
@dan_atar shares his key takeaways from Hot Lines 8 and 9, where new evidence explored integrated AF care, ablation strategies, exercise interventions, long-term blood pressure control, dementia risk, and prevention in patients with chronic kidney disease.
#ESCCongress
Dan Atar retweeted
Guess who I met today? The friend and expert @dan_atar who brought a “gift” : the printed article of incidental #CAC published in #NatureReview in cardiology #ESCCongress2026
Upcoming event: Cardio-Oncology should have broad interest across multiple disciplines:
event.checkin.no/225253/bhc-…
Participation is free of charge.
I am deeply honored by the occasion to receive the “outstanding research article 2025” award from our hospital OUS, for our BETAMI-DANBLOCK article in the NEJM.
This was huge teamwork, and I thanked the co-workers at OUS/UiO, my co-Chair, and the entire CV community in NO & DK.
Dan Atar retweeted
A great honor to welcome @ESC_President Thomas Lüscher to Bergen and the NCS Spring Meeting. His talk on AI and the future of cardiovascular medicine was truly thought-provoking.
(Take a look at the Elon Musk quote on the first photo🫣)
Glad to present online-streaming of JCS2026 with the session on guideline-changing evidence.
On demand streaming Site:
congre.co.jp/jcs2026/en/
Streaming Login: e416mb
A special thanks to Prof. Koichi Node, JCS2026-Chair, and Prof. Shinya Goto, my amazing host and co-Chairman.
Such an incredible experience: to be invited to the JCS2026, the Japanese Circulation Society, in beautiful Fukuoka. A marvelous congress with over 10.000 attendees.
A huge thank you to Prof. Koichi Node, the Congress Chair. And likewise to my host, Prof. Shinya Goto.
Dan Atar retweeted
Arrived in Tokyo. Huge hospitality @ Tokai University Hospital, by my friend Prof. Shinya Goto, a world renowned clinical scientist. Amazing experience just prior to embarking on the Shinkansen bullet train from Odawara to Fukuoka. My warmest thanks for this incredible reception.
Dan Atar retweeted
Rethinking β-blockers after MI
Our @NEJM Editorial integrates evidence from two recent IPD meta-analyses and outlines the emerging paradigm for β-blockade after MI.
👉 nejm.org/doi/full/10.1056/NE…
➡️ Time for personalized secondary prevention
@Borjaibanez1 @dan_atar @DLBHATTMD
CVCT stands out as a unique and most exciting “different” kind of conference where involvement across all stakeholders is key.
Huge congratulations to Faiez Zannad and Javed Butler to such a great achievement.
Honored to be back as faculty and to contribute to science.
Dan Atar retweeted
At #CVCT2025 I reviewed the nonlinear basic discovery arc underlying clinical development from autologous #CDCs #postMI to #deramiocel for #Duchenne #cardiomyopathy culminating in the blockbuster #HOPE3 trial by @Capricor. Odyssean journey!
@SmidtHeart @CIRMnews @CoalitionDMD
#CVCT2025: Beta-blockers post-MI have been discussed for the last 50 years. Early trials firmly documented survival benefits, but the entire landscape has changed. Contemporary trials now provide clear answers.
Join us, December 8-10, Washington DC: lnkd.in/dyg5BMwm
#CVCT
And here with the registration link:
ESC 365 - Are beta-blockers still indicated after myocardial infarction?
myesc.escardio.org/MyESC/s/e…